HC
Helen Louise Collins (CHIEF MEDICAL OFFICER) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Enliven Therapeutics, Inc. (ELVN). The largest single filing was $1.4M of ELVN (40,000 sh × $35.10, as filed), executed Mar 25. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
11
0 buys · 11 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$5.2M
shares × price, as filed
Last traded
Oct 19
Filed Oct 21
Median ADV $83.7M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
11 filings
Sector per market data · by filing · past 12 months
Most traded names
ELVNRecent filings
ELVNSALE
Enliven Therapeutics, Inc.
View filing →
$192K5,000 sh × $38.47
Exec Oct 19
Filed Oct 21 · 5:51 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $146K
2,916 sh × $50.03
Exec Sep 17
Filed Sep 21 · 5:22 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $228K
3,900 sh × $58.37
Exec Aug 17
Filed Aug 19 · 4:16 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $225K
4,247 sh across 2 lots
Exec Jul 17
Filed Jul 21 · 5:23 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $114K
2,599 sh × $43.87
Exec Jun 17
Filed Jun 22 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $137K
3,475 sh × $39.53
Exec May 18
Filed May 20 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $232K
4,860 sh across 2 lots
Exec Apr 17
Filed Apr 21 · 5:30 PM ET ELVNSALE Enliven Therapeutics, Inc. View filing → $1.4M
40,000 sh × $35.10
Exec Mar 25
Filed Mar 27 · 5:30 PM ET More filings →